Clinical Diagnostics

Comprehensive Clinical Test Catalogue

Advanced Diagnostic Solutions for Precision Medicine

NABL-accredited laboratory offering 93 specialized diagnostic tests across 11 clinical specialties. From prenatal genetics to infectious disease detection, we provide accurate, timely results that guide critical healthcare decisions.

93
Diagnostic Tests
11
Specialties
NABL
Accredited
Clinical Laboratory

Molecular Genetics Division

Rapid molecular detection panels for specific genetic disorders using targeted PCR, MLPA, and next-generation sequencing methodologies.

MDB-MG-001

Mitochondrial Genome Sequencing

Complete mitochondrial DNA (mtDNA) sequencing analyzing all 37 genes for diagnosis of mitochondrial disorders. Detects point mutations, deletions, and heteroplasmy levels in mitochondrial genome causing oxidative phosphorylation defects.

MethodologyNext-Generation Sequencing of complete mitochondrial genome (16.6 kb)
SampleBlood / Muscle tissue
TAT3-4 Weeks
MDB-MG-002

DMD-MLPA Del/Dup

Multiplex ligation-dependent probe amplification (MLPA) detecting exon-level deletions and duplications in disease-associated genes. Used for Duchenne/Becker muscular dystrophy (DMD), spinal muscular atrophy, and other conditions where copy number variants are pathogenic.

MethodologyMLPA (Multiplex Ligation-dependent Probe Amplification)
SampleBlood EDTA
TAT12-17 Days
MDB-MG-003

SMA SMN1/SMN2 Analysis

Molecular diagnosis of spinal muscular atrophy determining SMN1 gene copy number (deletions/duplications) and SMN2 copy number for prognostic information. Essential for newborn screening, carrier testing, and prenatal diagnosis.

MethodologyMultiplex PCR or MLPA determining SMN1 and SMN2 copy numbers
SampleBlood EDTA
TAT9-10 Days
MDB-MG-004

CFTR Hotspot Panel

Targeted mutation analysis of common CFTR gene mutations causing cystic fibrosis. Detects ~30-40 most prevalent mutations accounting for 80-90% of CF alleles in various populations. Used for carrier screening and diagnostic confirmation.

MethodologyMultiplex PCR or microarray detecting common CFTR mutations
SampleBlood EDTA
TAT2 Weeks
MDB-MG-005

JAK2 Reflex Panel

Sequential testing for myeloproliferative neoplasms analyzing JAK2 V617F mutation, then reflex to CALR exon 9 and MPL W515 mutations if JAK2 negative. Diagnoses polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

MethodologyReal-Time PCR for JAK2 V617F, followed by Sanger sequencing or fragment analysis for CALR and MPL if negative
SampleBlood EDTA
TAT5-8 Days